unknown
Stage
About
Aurovir Pharma GmbH develops gold-ion (aurothioglucose) based inhaled therapies for respiratory diseases, focusing on antiviral and anti-inflammatory treatments for viral pulmonary infections and other lung disorders.
Explore Aurovir Pharma GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.